These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 194426)

  • 1. [E1The mechanism of action of Lupidon].
    Remy W
    Z Hautkr; 1977 Apr; 52(8):470-4. PubMed ID: 194426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibody titers--curse in patients with recurring Herpes simplex virus infections under vaccination with heat-inactivated Herpes viruses].
    Remy W; Antoniadis G; Bockendahl H; Remy B
    Z Hautkr; 1976 Feb; 51(3):103-7. PubMed ID: 183397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled clinical study of the herpes antigens LUPIDON H and LUPIDON G].
    Weitgasser H
    Z Hautkr; 1977 Jun; 52(11):625-8. PubMed ID: 196421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G].
    Schmersahl P; Rüdiger G
    Z Hautkr; 1975 Feb; 50(3):105-12. PubMed ID: 179231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigen therapy of recurring herpes simplex with herpes simplex vaccine LUPIDON H and G].
    Schneider J; Rohde B
    Z Haut Geschlechtskr; 1972 Dec; 47(24):973-80. PubMed ID: 4346378
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases.
    Leventon-Kriss S; Rannon L; Joffe R
    Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogeny of herpes simplex viruses and lupidon].
    Petersen EE
    Z Hautkr; 1977 Apr; 52(7):417-26. PubMed ID: 193311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy experiences with herpes simplex antigen "Lupidon G".
    Djuanda S
    J Dermatol; 1976 Oct; 3(5):241-6. PubMed ID: 191480
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection.
    Heineman HS
    J Immunol; 1967 Jul; 99(1):214-22. PubMed ID: 4291444
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects and importance of human herpex simplex infections. Results of herpes antigen therapy].
    Wassilew SW; Nasemann T
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):25-7. PubMed ID: 6245350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
    Lesso J; Hána L; Matis J
    Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune response in genital herpes simplex virus infection.
    Corey L; Reeves WC; Holmes KK
    N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus antibodies in 18 patients submitted to immunosuppressive agents after renal transplantation].
    Ruffault A; Fauconnier B; Cartier F; Launois B
    Pathol Biol (Paris); 1975 May; 23(5):371-4. PubMed ID: 172840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type-specificity of slow-reacting complement-requiring neutralizing antibody (s-CRN antibody) to herpes simplex virus types 1 and 2 in rabbits].
    Sekine N
    Uirusu; 1983 Jun; 33(1):47-55. PubMed ID: 6316659
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.